Back
Akero Therapeutics Stock Price Chart
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
32
AKRO
Akero Therapeutics
Last Price:
19.25
Seasonality Move:
16.15%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.71 | Sell |
| 20-day SMA: | 22.11 | Sell |
| 50-day SMA: | 24.62 | Sell |
| 200-day SMA: | 28.95 | Sell |
| 8-day EMA: | 20.61 | Sell |
| 20-day EMA: | 21.98 | Sell |
| 50-day EMA: | 23.22 | Sell |
| 200-day EMA: | 27.52 | Sell |
Akero Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 26.69 | Sell |
| Chaikin Money Flow: | -152705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.92 - 24.38) | Sell |
| Bollinger Bands (100): | (20.07 - 26.07) | Sell |
Akero Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 18.93 while AKRO 8-day simple moving average is 20.71, which is a Sell signal.
- The stock price of AKRO is 18.93 while Akero Therapeutics 20-day SMA is 22.11, which makes it a Sell.
- Akero Therapeutics 50-day simple moving average is 24.62 while AKRO share price is 18.93, making it a Sell technically.
- AKRO stock price is 18.93 and Akero Therapeutics 200-day simple moving average is 28.95, creating a Sell signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
32
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Sell
The current Akero Therapeutics [AKRO] share price is $18.93. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.31B
Price in USD:
18.93
Share Volume:
828.31K
Akero Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
11.25
Sell
32
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 18.93 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 18.93 while AKRO 8-day exponential moving average is 20.61, which is a Sell signal.
- The stock price of AKRO is 18.93 while Akero Therapeutics 20-day EMA is 21.98, which makes it a Sell.
- Akero Therapeutics 50-day exponential moving average is 23.22 while AKRO share price is 18.93, making it a Sell technically.
- AKRO stock price is 18.93 and Akero Therapeutics 200-day simple moving average is 27.52, creating a Sell signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is -1.33, suggesting Akero Therapeutics is a Sell
- Akero Therapeutics Relative Strength Index (RSI) is 26.69, which suggest Akero Therapeutics is oversold
- The Bollinger Bands (25) for Akero Therapeutics is (20.92 - 24.38), which suggest Akero Therapeutics is a Sell
- The Bollinger Bands (100) for Akero Therapeutics is (20.07 - 26.07), which suggest Akero Therapeutics is a Sell
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.